Advances in the development of molecular genetic tools for Mycobacterium tuberculosis
- PMID: 29941353
- DOI: 10.1016/j.jgg.2018.06.003
Advances in the development of molecular genetic tools for Mycobacterium tuberculosis
Abstract
Mycobacterium tuberculosis, a clinically relevant Gram-positive bacterium of great clinical relevance, is a lethal pathogen owing to its complex physiological characteristics and development of drug resistance. Several molecular genetic tools have been developed in the past few decades to study this microorganism. These tools have been instrumental in understanding how M. tuberculosis became a successful pathogen. Advanced molecular genetic tools have played a significant role in exploring the complex pathways involved in M. tuberculosis pathogenesis. Here, we review various molecular genetic tools used in the study of M. tuberculosis. Further, we discuss the applications of clustered regularly interspaced short palindromic repeat interference (CRISPRi), a novel technology recently applied in M. tuberculosis research to study target gene functions. Finally, prospective outcomes of the applications of molecular techniques in the field of M. tuberculosis genetic research are also discussed.
Keywords: Drug resistance; Ggram-positive; Molecular genetic tools; Mycobacterium tuberculosis; Recombineering.
Copyright © 2018. Published by Elsevier Ltd.
Similar articles
-
Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of Mycobacterium tuberculosis infection.J Antimicrob Chemother. 2022 Feb 23;77(3):615-619. doi: 10.1093/jac/dkab437. J Antimicrob Chemother. 2022. PMID: 34850009
-
A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis.mBio. 2020 Jan 28;11(1):e02364-19. doi: 10.1128/mBio.02364-19. mBio. 2020. PMID: 31992616 Free PMC article.
-
Strategies of genome editing in mycobacteria: Achievements and challenges.Tuberculosis (Edinb). 2016 May;98:132-8. doi: 10.1016/j.tube.2016.03.005. Epub 2016 Mar 26. Tuberculosis (Edinb). 2016. PMID: 27156629 Review.
-
Comparative Genomic Analysis of Mycobacteriaceae Reveals Horizontal Gene Transfer-Mediated Evolution of the CRISPR-Cas System in the Mycobacterium tuberculosis Complex.mSystems. 2021 Jan 19;6(1):e00934-20. doi: 10.1128/mSystems.00934-20. mSystems. 2021. PMID: 33468705 Free PMC article.
-
The future of CRISPR in Mycobacterium tuberculosis infection.J Biomed Sci. 2023 May 27;30(1):34. doi: 10.1186/s12929-023-00932-4. J Biomed Sci. 2023. PMID: 37245014 Free PMC article. Review.
Cited by
-
Low-cost anti-mycobacterial drug discovery using engineered E. coli.Nat Commun. 2022 Jul 7;13(1):3905. doi: 10.1038/s41467-022-31570-3. Nat Commun. 2022. PMID: 35798732 Free PMC article.
-
Efficient genome editing in pathogenic mycobacteria using Streptococcus thermophilus CRISPR1-Cas9.Tuberculosis (Edinb). 2020 Sep;124:101983. doi: 10.1016/j.tube.2020.101983. Epub 2020 Aug 12. Tuberculosis (Edinb). 2020. PMID: 32829077 Free PMC article.
-
Improving the stability of the TetR/Pip-OFF mycobacterial repressible promoter system.Sci Rep. 2019 Apr 8;9(1):5783. doi: 10.1038/s41598-019-42319-2. Sci Rep. 2019. PMID: 30962489 Free PMC article.
-
Mycobacterial Genetic Technologies for Probing the Host-Pathogen Microenvironment.Infect Immun. 2023 Jun 15;91(6):e0043022. doi: 10.1128/iai.00430-22. Epub 2023 May 30. Infect Immun. 2023. PMID: 37249448 Free PMC article. Review.
-
Enhanced immunogenicity of Mycobacterium bovis BCG through CRISPRi mediated depletion of AftC.Cell Surf. 2022 Nov 11;8:100088. doi: 10.1016/j.tcsw.2022.100088. eCollection 2022 Dec. Cell Surf. 2022. PMID: 36405350 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous